DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER (dopamine hydrochloride)
Dopamine Hydrochloride in Dextrose 5% is used to improve hemodynamic status in patients experiencing shock. It helps patients with distributive shock or shock resulting from reduced cardiac output. This medication is prescribed to stabilize blood flow and heart function during these critical states.
How DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER Works
This drug works by activating several types of receptors, including dopamine D1 and D2, beta-1, and alpha-1 receptors. As a natural catecholamine and precursor to norepinephrine, it triggers different physiological responses depending on the specific dose administered. These interactions help regulate the body's cardiovascular response.
Details
- Status
- Prescription
- First Approved
- 1983-09-30
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER Approval History
What DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER Treats
1 indicationsDOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER is approved for 1 conditions since its original approval in 1983. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Shock
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
MoA expansion candidates
Same target(s), different indications — where else is this mechanism being explored?
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT01482559 HIP | HIP-FP7-BrePco 2010-023988-17 | Ph 3 | terminated | Management of Hypotension In the Preterm Infant |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER FDA Label Details
Indications & Usage
FDA Label (PDF)DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER is indicated for the treatment of Shock.
Track DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.